Pricing Log in Create free account
Friday 6 November 2026 Export PLSE’s income statement to Excel — free account

Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.

Revenue
+359.3%
EPS
−10.3%
Free cash flow
−1,180.5%

Quarter to September 2026, against a year earlier

53.15 3.91 −6.85%
Market cap
$3.9B
P/E
0.0×
Fwd P/E
−38.1×
Dividend yield
—
F-score
n/a
Altman Z
31.41
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Pulse Biosciences, Inc (PLSE) EV/EBITDA

Alert me on EV/EBITDA

Pulse Biosciences, Inc has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 0.0× —
FY2022 0.0× —
FY2021 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 0.0× —
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
6 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

EV/EBITDA against peers

Company EV/EBITDA
PLSE Pulse Biosciences, Inc n/m
MMED MiniMed Group, Inc. compare n/m
NVST Envista Holdings Corporation compare 10.3×
STVN Stevanato Group S.p.A. compare 11.3×
MMSI Merit Medical Systems, Inc. compare 15.5×
ICUI ICU Medical, Inc. compare 16.0×
TFX Teleflex Incorporated compare 35.7×
WRBY Warby Parker Inc. compare 50.2×
ATRC AtriCure, Inc. compare 83.7×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on PLSE